Cataplexy

Narcolepsy and Hypersomnia

Volumn , Issue , 2006, Pages 49-62

  Guilleminault, Christian ^a   Lee, Ji Hyun ^a   Arias, Viola ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84857384021     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (75)

1. Henneberg R Uber genuine narcolepsie Neurol Ibe 1916; 30:282-290.
2. Westphal C Eigenthumlich mit einschlafen verbundene anfalle Arch Psychiatr-Nervenks 1877; 7:631-633.
3. Gelineau JB De la narcolepsie Gaz des Hop(Paris) 1880; 53:626-628, 1880; 54:635-637.
4. Lowenfeld L. Uber Narkolepsie. Munch. Med. Wochenschr. 1902; 49:1041-1045.
5. Adie W Idiopathic narcolepsy: a disease sui generic, with remarks on the mechanisms of sleep Brain 1928; 49:257-306.
6. Daniels L Narcolepsy Medicine 1934; 13:1-122.
7. Mignot E, Lammers GJ, Ripley B, Okun M, Nevsimalova S, Overeem S, Vankova J, Black J, Harsh J, Bassetti C, Schrader H, Nishino S The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypocretins Arch Neurol 2002; 59:1553-1562.
8. Guilleminault C Gelb M Clinical aspects and features of cataplexy in Negative motor phenomena S Fahn M Hallet H O Ludders CD Marsden (eds) Advances in Neurology vol.67 Philadelphia Lipincott-Raven (publ.) 1995 pp. 65-77.
9. Guilleminault C, Wilson R, Dement WC A study on cataplexy Arch Neurol 1974; 31:255-261.
10. Gelb M, Guilleminault C, Kraemer H, Lin S, Moon S, Dement WC, Mignot E. Stability of cataplexy over several months-information for the design of therapeutic trials Sleep 1994; 17:265-273.
11. Dauvilliers Y, Montplaisir J, Molinari N, Carlander B, Ondze B, Besset A, Billiard M Age at onset of narcolepsy in two large populations of patients in France and in Quebec Neurology 2001; 57:2029-2033.
12. Guilleminault C, Pelayo R Narcolepsy in prepubertal children Ann Neurol 1998; 43:135-142.
13. Dauvilliers Y, Bazin M, Ondze’ B, Bera O, Bazin M, Besset A, Billiard M Severity of narcolepsy among French of different ethnic origins Sleep 2002; 25:50-55.
14. Challamel MJ, Mazzola ME, Nevsimalova S, Cannard C, Louis J, Revol M Narcolepsy in children Sleep 1994; 17:S17-S20.
15. Philipart M, Eugel J, Zimmerman E Gelastic cataplexy in Niemann-Pick disease type C and related variants without sphigomyelinase deficiency Ann Neurol 1983; 14:492-493.
16. Kambayashi T, Abe M, Fujimoto S, Miyachi T, Takahashi T, Yano T, Sawaishi Y, Arii J, Szilagyi G, Shimizu T Hypocretin deficiency in Niemann-Pick type C with cataplexy Neuropediatrics 2003; 34: 52-53.
17. Vankova J, Stepanova J, Jech R, Elleder M, Ling L, Mignot E, Nishino S, Nevsimalova S Sleep disturbances and hypocretin deficiency in Niemann-Pick disease type C Sleep 2003; 26:427-430.
18. Einhaus SI, Stanford RA Craniopharyngioma in Albright AL, Pollack IF, Adelson PD (eds) Principles and practice of pediatric neurosurgery New York Thieme 1999; 99:545-562.
19. Schwartz WJ, Stakes JW, Hobson JA Transient cataplexy after removal of a craniopharyngioma Neurology 1984; 34:1372-1375.
20. Malik S, Boeve BF, Krahn LE, Silber MH Narcolepsy associated with other central nervous system disorders Neurology 2001; 57:539-541.
21. Scammell TE, Nishino S, Mignot E, Saper CB Narcolepsy and low CSF orexin (hypocretin) concentration after a diencephalic stroke Neurology 2001; 56:1751-1753.
22. Arii J, Kambayashi T, Tanabe Y, Ono J, Nishino S, Kohno Y A hypersomnolent girl with decrease CSF hypocretin level after removal of a hypothalamic tumor Neurology 2001; 56:1775-1776.
23. Marcus CL, Trescher WH, Halbowere AC, Luiz J Secondary narcolepsy in children with brain tumor Sleep 2000; 25:435-439.
24. Landolfi JC, Nadkarni M Paraneoplastic limbic encephalitis and possible narcolepsy in a patient with testicular cancer: case study Neuro-oncol 2003; 5:214-215.
25. D’Cruz OF, Vaughn BV, Gold SH, Greenwood RS Symptomatic cataplexy in pontomedullary lesions Neurology 1994; 44:2189-2191.
26. Aldrich MS, Naylor MW. Narcolepsy associated with lesions of the diencephalons. Neurology 1989; 39:1505-1508.
27. Ma TK, Ang LC, Mamelak M, Kish SJ, Young B, Lewis AJ Narcolepsy secondary to 4th ventricle subependynoma Can J Neurol Sci 1996; 23:59-62.
28. Stahl SM, Layzer RB, Aminoff MJ, Towsend JJ, Feldon S Continuous cataplexy in a patient with a mid-brain tumor; the limp man syndrome Neurology 1980; 30:1115-1118.
29. Passouant P, Baldy-Moulinier M, Aussilloux C Etat de mal cataplectique au cours d’une maladie de Gelineau: influence de la clomipramine Rev Neurol (Paris) 1970; 123:56-60.
30. Guilleminault C, Heinzer R, Mignot E, Black J Investigation into the neurological basis of narcolepsy Neurology 1998; 50 suppl 1:S8-S15.
31. Overeem S, Taal W, Ocal Geizici E, Lammers GJ, Van Dijk JG Is motor inhibition during laughter due to emotional or respiratory influences? Psychophysiol 2004; 41:254-258.
32. Maillard D, Roby A, Willer JC Depressive effect of coughing on spinal monosynaptic reflexes in conscious man Clin Sci 1983; 65:57-64.
33. Nielsen J, Crone C, Hultborn H H-reflexes are smaller in dancers from the Royal Danish Ballet than in well-trained athletes Eur J Appl Physiol Occ Med 1993; 66:116-121.
34. Oishi K, Kimura M, Yasukawa M, Yoneda T, Maeshima T. Amplitude reduction of H-reflex during mental movement simulation in elite athletes. Beh. Brain Res. 1994; 62:55-61.
35. Siegel JM, Fahringer HM, Tomaszewski KS, Kaitin K, Kilduff T, Dement WC Heart rate and blood pressure change associated with cataplexy in canine narcolepsy Sleep 1986; 9:216-221.
36. Guilleminault C, Quera-Salva MA, Mancuso J, Hayes B Narcolepsy-cataplexy heart rate and blood pressure Sleep 1986; 9:222-226.
37. Guilleminault C, Mignot E, Aldrich MS Quera-Salva MA, Tiberge M, Partinen M Prazosin is contraindicated in patients with narcolepsy Lancet 1988; 2:511.
38. Aldrich MS, Rogers AE Exacerbation of human cataplexy by prazosin Sleep 1989; 12:254-259.
39. Wu MF, Gulyani S, Yao E, Mignot E, Phan B, Siegel JM Locus coeruleus neurons: cessation of activity during cataplexy Neurosc 1999; 91:1389-1399.
40. Wu MF, John J, Boehmer LN, Yau D, Nguyen GB, Siegel JM Activity of dorsal raphe cells across the sleep-waking cycle and during cataplexy in narcoleptic dogs J Physiol 2004; 554:202-215.
41. John J, Wu MF, Boehmer LN, Siegel JM Cataplexy-active neurons in the hypothalamus; implication for the role of histamine in sleep and waking behavior Neuron 2004; 42:619-634.
42. Kushida CA, Baker TL, Dement WC Electroencephalographic correlates of cataplectic attacks in narcoleptic canines Electroencephal Clin Neurol 1985; 61:61-70.
43. Willie JT, Chemelli RM, Sinton CM Tokita S, Williams SC, Kisanuki YY, Marcus JN, Lee C, Elmquist JK, Kohmeier KA, Yanagigawa M Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of non-REM and REM sleep regulatory processes Neuron 2003; 38:715-730.
44. Kisanuki YY, Chemelli RM, Tokita S, Willie JT, Sinton CM, Yanagigawa Behavioral and polysmnographic characterization of orexin-1 and orexin-2 receptor double knock-out mice. Sleep 2001; 24; A22.
45. Guilleminault C, Aftab FA, Karadeniz D, Philip P, Leger D Problems associated with switch to Modafinil-a novel alerting agent in Narcolepsy Eur J Neurology 2000; 7:381-384.
46. Delashaw JB, Foutz AS, Guilleminault C, Dement WC Cholinergic mechanisms and cataplexy in dogs Exp H Neurol 1979; 66:745-757.
47. Foutz AS, Delashaw JB, Guilleminault C, Dement WC Monoaminergic mechanisms and experimental cataplexy Ann Neurol 1981; 10:369-376.
48. Mignot E, Guilleminault C, Bowersox S, Frustofer B, Nishino S, Maddaluno J, Ciaranello R, Dement WC Central alpha-1 adrenoceptor subtypes in narcolepsy-cataplexy a disorder of REM sleep Brain Res 1989; 490:186-191.
49. Mignot E, Renaud A, Nishino S, Arrigoni J, Guilleminault C, Dement WC Canine narcolepsy is preferentially controlled by adrenergic mechanisms: evidence using monoamine selective uptake inhibition and release enhancers Psychopharmacol 1993; 113:76-82.
50. Nishino S, Mignot E Pharmacological aspects of human and canine narcolepsy Pro Neurobiol 1997; 57:27-78.
51. Juji T, Satake M. Honda Y, Doi Y HLA antigens in Japanese patients with narcolepsy Tissue Antigens 1984; 24:316-319.
52. Mignot E, Lin X, Arrigoni J, Macaubas C, Olive F, Hallmayer J, Underhill P, Guilleminault C, Dement WC, Grumet FC DQB1-0602 and DQA1-0102 (Dqw1) are better markers than DR2 for narcolepsy in caucasian and black Americans Sleep 1994; 17:S60-S67.
53. Mignot E, Hayduk R, Black J, Grumet FC, Guilleminault C HLA DQB10602 is associated with cataplexy in 509 narcoleptic patients Sleep 1997; 20(11):1012-20.
54. Neely S, Rosenberg R, Spire J, Antel J, Arnason B HLA antigens in narcolepsy Neurology 1987; 37:1858-1860.
55. Matsuki K, Grumet FC, Lin X, Guilleminault C, Dement WC, Mignot E. HLA DQB1-0602 rather than HLA DRw15 (DR2) is the disease susceptibility gene in Black narcolepsy Lancet 1992; 339:1052.
56. Mignot E, Lin L, Rogers W, Honda Y, Qiu X, Okun M, Hohjoh H, Miki T, Hsu S, Leffell M, Grumet F, Fernandez-Vina M, Honda M, Risch N Complex HLA-DR and DQ interaction confer risk of narcolepsy-cataplexy in three ethnic groups Am J Hum. Genet 2001; 68:686-699.
57. Pelin Z, Guilleminault C, Rich NJ, Grument FC, Mignot E HLA DQB1-0602 homozygousity increases relative risk for narcolepsy but not disease severity in two ethnic groups Tissue Antigens 1998; 51: 96-100.
58. Hungs M, Mignot E Hypocretin/orexin, sleep and narcolepsy Bioessays. 2001; 23:397-408.
59. Chabas D, Taheri S, Renier C, Mignot E The genetics of narcolepsy Annu Rev Genomics Hum Genet 2003; 4:459-483.
60. Guilleminault C, Mignot E, Grumet FC Familial patterns of narcolepsy Lancet 1989; 335:1376-1379.
61. Vossler DG, Wyler AR, Wilkus RJ, Gardner-Walker G, Vlcek BW Cataplexy and monoamine deficiency in Norrie disease Neurology 1996; 46:1258-1261.
62. Koch H, Craig I, Dahlitz M, Denny R, Parkers D Analysis of the monoamine oxydase genes and the Norrie disease gene locus in narcolepsy Lancet 1999; 353:645-646.
63. Dauvilliers Y, Neidhart E, Lecendreny M, Billard M, Tafti M MAO-A and COMT polymorphisms and gene effects in narcolepsy Mol Psychiatr 2001; 6:367-372.
64. Nishino S, Ripley B, Overseem S, Lammers GL, Mignot E Hypocretin (orexin) deficiency in human narcolepsy Lancet 2000; 355:39-40.
65. Anic-Labat S, Guilleminault C, Kraemer HC, Meehan J, Arrigoni J, Mignot E Validation of a cataplexy questionnaire in 983 sleep disorders patients Sleep 1999; 22:7-87.
66. Guilleminault C, Mignot E, Partinen M Controversies in the diagnosis of narcolepsy Sleep 1994; 17:S1-S6.
67. Hublin C, Kaprio J, Partinen M, Koskenvuo M, Heikkila K, Kosmikies S, et al. The prevalence of narcolepsy: an epidemiological study of the Finnish twin cohort. Ann. Neurol. 1994; 35:709-716. 1994.
68. Thannickal TC, Moore RY, Nienhauis R, Ramanathan L, Gulyani S, Aldrich M, Conford M, Siegel JM Reduced number of hypocretin neurons in human narcolepsy Neuron 2000; 27:467-474.
69. Peyron C, Faraco J, Rogers W, Ripley B, Overeem S, Charnay Y, Mignot E A mutation in a case of early onset narcolepsy and generalized absence of hypocretin peptides in human narcoleptic brains Nat Med 2000; 6:991-997.
70. Thannickal TC, Siegel JM, Nienhuis R, Moore RY Pattern of hypocretin (orexin) soma and axon loss and gliosis in human narcolepsy Brain Pathol 2003; 13:340-351.
71. Mignot E, Chen W, Black J On the value of measuring CSF-Hypocretin-1 in diagnosing narcolepsy 2003; 26:646-649.
72. Guilleminault C, Grumet FC HLA DR2 and narcolepsy: Not all narcoleptic-cataplectic patients are DR2 Hum Immunol 1986; 17:1-2.
73. Dalal MA, Schuld A, Pollmacher T Undetectable CSF level of orexin-A (hypocretin-1) in a HLA DR2 negative patient with narcolepsy-cataplexy J Sleep Res 2002; 11:273.
74. Khatami R, Maret S, Werth E, Retey J, Schmid D, Maly F, Tafti M, Bassetti C Monozygotic twins concordant for narcolepsy-cataplexy without any detectable abnormality in the hypocretin (orexin) pathway Lancet 2004; 363:1199-1200.
75. Neely S Rosenberg R, Spire JP, Antel J, Armason BEW HLA antigens in narcolepsy Neurology 1987; 37:1858-1860.